A Phase 1/2 Trial of TC-510 In Patients With Advanced Mesothelin-Expressing Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Mesothelioma
Related studies linked through entity extraction aliases.
Study of Safety, Pharmacokinetic and Efficacy of APG-5918 in Advanced Solid Tumors or Lymphomas
- Status
- UNKNOWN
- Phase
- PHASE1
Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Study of RSO-021 in Patients With Malignant Pleural Effusion Due to Advanced/Metastatic Solid Tumors Including Mesothelioma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
- Status
- RECRUITING
- Phase
- PHASE1
A Study of HFB200301 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Study of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Study of Immunotherapy Drugs Nivolumab and Ipilimumab in Patients w/Resectable Malignant Peritoneal Mesothelioma
- Status
- COMPLETED
- Phase
- PHASE2
Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs
- Status
- WITHDRAWN
- Phase
- N/A
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
- Status
- RECRUITING
- Phase
- N/A
UNITO-001- Study in HRR/PDL1 Positive MPM/NSCLC
- Status
- UNKNOWN
- Phase
- PHASE2
Study of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
A Phase I Study of IAG933 in Patients With Advanced Mesothelioma and Other Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Intratumor Injection of Anti-Mesothelin Immunotoxin LMB-100 With Ipilimumab in Malignant Mesothelioma
- Status
- TERMINATED
- Phase
- PHASE1
Efficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients with PD1-high MRNA Expressing Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome
- Status
- RECRUITING
- Phase
- N/A
Study to Evaluate VT3989 in Patients With Metastatic Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Risk Factors of Immune-ChEckpoint Inhibitors MEdiated Liver, Gastrointestinal, Endocrine and Skin Toxicity
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Effects of Itraconazole and Rifampin on the Blood Tazemetostat Levels
- Status
- COMPLETED
- Phase
- PHASE1